Why Is Mounjaro Not Working for Me?

Is it too early to judge whether Mounjaro is working?

One of the questions our prescribers hear most often is some version of: "I've been on it for a month and the scales haven't moved, why is my Mounjaro not working?" The honest answer is that a month at 2.5 mg is rarely enough time to reach a conclusion. The starter dose is there to let your body adjust, not to drive weight loss, and the titration journey to a maintenance dose typically takes three to five months. In the SURMOUNT-1 trial, the largest weight reductions were seen over 72 weeks, the full arc of treatment, not the opening chapter.

Week-to-week scale changes are also noisy. Fluid retention, cycle timing, a salty meal the night before: all of these can mask real fat loss on a given morning. Tracking a four-week trend, rather than daily weigh-ins, gives a truer picture. If you are still in the early months and your dose is still being titrated, progress being slow is not the same thing as Mounjaro not working, it may simply mean you haven't yet arrived at your therapeutic dose. The timeline for how long Mounjaro takes to work is longer than most people expect when they start.

That said, if you feel Mounjaro is not working for you after several months at your highest tolerated dose without meaningful change, that is a different conversation, and one worth having with your prescriber. Biology varies.

What lifestyle and behavioural factors can undermine the medicine?

Tirzepatide suppresses appetite and slows gastric emptying, but it works alongside your choices rather than instead of them. When Mounjaro isn't producing weight loss, the first things worth reviewing honestly are what has actually changed about eating patterns and activity. The medicine lowers hunger signals, but if highly palatable, calorie-dense food is still very accessible (kept at the front of the fridge door, in a desk drawer, in easy reach) the reduced hunger may not be enough to offset it.

Protein intake deserves particular attention. On a reduced-calorie diet, getting adequate protein (aiming for around 1.2–1.6 g per kg of body weight daily is a common target, though a dietitian can personalise this) helps preserve muscle mass and keeps satiety strong between meals. Sleep and stress are less obvious but genuinely significant: poor sleep and elevated cortisol both counteract the metabolic signals tirzepatide is trying to support.

Some medications can also interfere. Certain antidepressants, antipsychotics, steroids and insulin-sensitising drugs affect weight independently. If you started or changed any of these around the same time as Mounjaro, it is worth raising with your prescriber. The overview of how Mounjaro works explains its dual-receptor mechanism, which is relevant background if you want to understand what you are working with and what you are working against. The treatment options page also sets out the broader picture of what clinical weight management involves.

Could the dose need adjusting, or is something else going on clinically?

If you have been titrated to the highest dose you can tolerate and progress has genuinely stalled over six to eight weeks, the clinical question shifts. NICE's appraisal of tirzepatide notes that continuing treatment should be reviewed if weight loss is less than 5% after six months at the highest tolerated dose, as described in NICE technology appraisal TA1026. That is a formal threshold, but it is also a useful benchmark for a personal review.

Clinically, a plateau can point to several things. Your highest tolerated dose may be lower than the trial's 15 mg maintenance dose, tolerability varies, and there is no failure in that. Underlying thyroid function, insulin resistance, or hormonal factors can all independently affect the rate of weight loss and are worth investigating with your GP if they haven't been. There are also questions around absorption: if injections have not been rotating sites properly (abdomen, thigh and upper arm each respond slightly differently), or if a pen was stored incorrectly, the drug may not have been working optimally. The NHS tirzepatide patient page at nhs.uk covers storage and administration details to cross-check against.

The question of what to do if Mounjaro isn't working is one a prescriber can work through with you properly. Changing dose, reviewing interacting medications, investigating underlying conditions, or discussing whether a different treatment approach suits you better, those are clinical decisions, not things to resolve by reading online. Speak to our prescribers if you'd like that conversation.

Does experiencing fewer side effects mean the medicine has stopped working?

Several people worry that once the nausea fades, the medicine has lost its effect. It hasn't. The gastrointestinal symptoms that are common at the start of treatment (nausea, digestive changes, early fullness) tend to ease as the body adjusts, usually within a few weeks of each dose step. That settling is a normal part of treatment, not a sign the drug is wearing off.

It is worth separating the question of tolerability from the question of efficacy. If the side effects have gone but appetite suppression has also noticeably reduced, that is a different and more relevant observation to flag. The broader look at why tirzepatide may not be working covers the pharmacological angle in more detail. The distinction between side effects quietening (expected and welcome) and the appetite-suppression effect genuinely diminishing (worth discussing) is one our clinical team can help you assess. You can read more about the clinical team behind nume and how consultations are structured if you want to understand what that conversation looks like before you start it.